ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

alpha-D-lactose → (S)-1-[2,3-dihydroxy-5-hydroxymethyl-4-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-furan-2-ylmethyl]-4-isobutyl-pyrrolidin-2-one

HRID 1793801
印刷

反応式

HRID 1793801 の反応式
CC(C[C@H](CN)CC(O)=O)C.OC1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O.[OH:35][CH:36]1[CH:41]([OH:42])[CH:40]([O:43][CH:44]2[CH:49]([OH:50])[CH:48]([OH:51])[CH:47]([OH:52])[CH:46]([CH2:53][OH:54])[O:45]2)[CH:39]([CH2:55][OH:56])[O:38][CH:37]1[N:57]1[CH2:61][C@@H:60]([CH2:62][CH:63]([CH3:65])[CH3:64])[CH2:59][C:58]1=[O:66].O[C@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O>>[CH2:62]([C@@H:60]1[CH2:61][N:57]([CH2:37][C:36]2([OH:35])[CH:41]([OH:42])[CH:40]([O:43][CH:44]3[CH:49]([OH:50])[CH:48]([OH:51])[CH:47]([OH:52])[CH:46]([CH2:53][OH:54])[O:45]3)[CH:39]([OH:38])[CH2:55][O:56]2)[C:58](=[O:66])[CH2:59]1)[CH:63]([CH3:65])[CH3:64].[OH:35][C:36]1([CH2:37][N:57]2[CH2:61][C@@H:60]([CH2:62][CH:63]([CH3:65])[CH3:64])[CH2:59][C:58]2=[O:66])[CH:41]([OH:42])[CH:40]([O:43][CH:44]2[CH:49]([OH:50])[CH:48]([OH:51])[CH:47]([OH:52])[CH:46]([CH2:53][OH:54])[O:45]2)[CH:39]([CH2:55][OH:56])[O:38]1.[OH:35][CH:36]1[CH:41]([OH:42])[CH:40]([O:43][CH:44]2[CH:49]([OH:50])[CH:48]([OH:51])[CH:47]([OH:52])[CH:46]([CH2:53][OH:54])[O:45]2)[CH:39]([CH2:55][OH:56])[O:38][CH:37]1[N:57]1[CH2:61][C@@H:60]([CH2:62][CH:63]([CH3:64])[CH3:65])[CH2:59][C:58]1=[O:66]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 84571alpha-D-lactoseHCID 440995(+)-Lactose5 回HCID 5486971Pregabalin4 回HCID 69625525(S)-1-[3,4-dihydroxy-6-hydroxymethyl-5-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yl]-4-isobutyl-pyrrolidin-2-one2 回

生成物 3

HCID 69625278
(S)-1-[2,3-dihydroxy-5-hydroxymethyl-4-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-furan-2-ylmethyl]-4-isobutyl-pyrrolidin-2-one
HCID 69625379(S)-4-isobutyl-1-[2,3,5-trihydroxy-4-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-ylmethyl]-pyrrolidin-2-one
HCID 69625525(S)-1-[3,4-dihydroxy-6-hydroxymethyl-5-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yl]-4-isobutyl-pyrrolidin-2-one

実験手順

Pregabalin undergoes a Maillard reaction to form conjugates with lactose in formulated product. Seven of these conjugates, which exist in the lactam form of the pregabalin moiety, were generated in milligram to gram quantities by heating pregabalin in the presence of lactose. The compounds were then isolated by preparative liquid chromatography. The assigned structures of the isolated lactose-lactam conjugates were consistent with the NMR and mass spectrometry data. Of the seven compounds identified, one compound ((S)-1-[3,4-dihydroxy-6-hydroxymethyl-5-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yl]-4-isobutyl-pyrrolidin-2-one) is the Maillard reaction product of pregabalin and lactose. The lactose used in the reaction was originally the α-lactose. However, upon dissolution in the above reaction conditions, the lactose rapidly equilibrates between the α and β forms. The conjugate (S)-1-[3,4-dihydroxy-6-hydroxymethyl-5-(3,4,5 -trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yl]-4-isobutyl-pyrrolidin-2-one is the β-anomer. Two of the compounds ((S)-4-isobutyl-1-[2,3,5-trihydroxy-4-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-ylmethyl]-pyrrolidin-2-one and (S)-1-[2,3-dihydroxy-5-hydroxymethyl-4-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-furan-2-ylmethyl]-4-isobutyl-pyrrolidin-2-one) result from the Amadori rearrangement of (S)-1-[3,4-dihydroxy-6-hydroxymethyl-5-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yl]-4-isobutyl-pyrrolidin-2-one. One product is the β-furanose form ((S)-1-[2,3-dihydroxy-5-hydroxymethyl-4-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-furan-2-ylmethyl]-4-isobutyl-pyrrolidin-2-one), and the other is the β-pyranose form ((S)-4-isobutyl-1-[2,3,5 -trihydroxy-4-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-ylmethyl]-pyrrolidin-2-one). The remaining four conjugates are monosaccharides, resulting from the Maillard reaction/Amadori rearrangement of pregabalin with either the galactose ((S)-4-isobutyl-1-(2,3,4,5-tetrahydroxy-tetrahydro-pyran-2-ylmethyl)-pyrrolidin-2-one and (S)-4-isobutyl-1-(2,3,4,5-tetrahydroxy-tetrahydro-pyran-2-ylmethyl)-pyrrolidin-2-one) or glucose ((S)-4-isobutyl-1-(2,3,4,5-tetrahydroxy-tetrahydro-pyran-2-ylmethyl)-pyrrolidin-2-one and (S)-4-isobutyl-1-(2,3,4-trihydroxy-5-hydroxymethyl-tetrahydro-furan-2-ylmethyl)-pyrrolidin-2-one) moiety of lactose. In separate experiments, pregabalin (300 mg) was reacted in 5 mL H2O (adjusted to pH 11 with KOH) at 80° C. with glucose (600 mg) and galactose (600 mg). In the glucose reaction, a 3:1 mixture of (S)-4-isobutyl-1-(2,3,4,5-tetrahydroxy-tetrahydro-pyran-2-ylmethyl)-pyrrolidin-2-one and (S)-4-isobutyl-1-(2,3,4-trihydroxy-5-hydroxymethyl-tetrahydro-furan-2-ylmethyl)-pyrrolidin-2-one resulted. In the galactose reaction, a 5:1 mixture of (S)-4-isobutyl-1-(2,3,4,5-tetrahydroxy-tetrahydro-pyran-2-ylmethyl)-pyrrolidin-2-one and (S)-4-isobutyl-1-(2,3,4,5-tetrahydroxy-tetrahydro-pyran-2-ylmethyl)-pyrrolidin-2-one resulted. These experimental results support the structural assignments of the monosaccharide conjugates.

後処理

  1. customa Maillard reaction
  2. customto form
  3. customThe compounds were then isolated by preparative liquid chromatography
  4. dissolutionHowever, upon dissolution
  5. customin the above reaction conditions

出典と根拠

ORDレコード
ord-b346317f3ee84d22b2d9096ad462a1bb
出典データセット
uspto-grants-2006_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07022678B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート